Podiatrists in Torrance, CA Accepting Medicare
45 Podiatrists found. Showing 41 - 45
 Gavin Genzo Tsuchida, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2780 Skypark Dr Ste 100, Torrance, CA 90505 Phone: 310-326-8551 |
Roland Carroll, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 21250 Hawthorne Blvd, Suite 160, Torrance, CA 90503 Phone: 310-540-1213 Fax: 310-540-7405 |
Dr. Jeffrey Demian, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 22633 Anza Ave, Torrance, CA 90505 Phone: 760-256-1004 |
Robert Roy Anavian, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 23456 Hawthorne Blvd, Suite 270, Torrance, CA 90505 Phone: 310-375-1417 |
Dr. Gregory Jay Teles, D.P.M. Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 23365 Hawthorne Blvd Ste 101, Torrance, CA 90505 Phone: 310-326-0202 Fax: 310-326-5826 |
News Archive
New discovery cracks code of metabolic pathway that allows certain cancerous tumors to thrive
In a breakthrough discovery at the Children's Medical Center Research Institute at UT Southwestern (CRI), a research team led by Ralph DeBerardinis, M.D., Ph.D., has taken a significant step in cracking the code of an atypical metabolic pathway that allows certain cancerous tumors to thrive, providing a possible roadmap for defeating such cancers.
Merck to deliver Composite Software data virtualization case study at Pharma Data Analytics Conference
Merck & Co., Inc., a global healthcare leader operating in more than 140 countries to deliver innovative health solutions, will present a Composite Software data virtualization case study at the Pharma Data Analytics Conference on July 10 in Philadelphia, PA.
GEN article reports on new drug research and development costs
A policy specialist and a healthcare economist both say that the oft-quoted cost of $1.32 billion to bring a new drug to market does not hold up to close scrutiny, reports Genetic Engineering & Biotechnology News.
Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis
With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.
› Verified 2 days ago
Physical Therapists
Occupational Therapists
Chiropractors
Speech-Language Pathologists
Optometrists
Podiatrists
Audiologists